A New Angle on
Non-opioid Pain Relief

Isosceles Pharmaceuticals is a preclinical stage pharmaceutical company, currently developing intravenous formulations of synthetic Cannabidiol (CBD), one of the many active chemicals in cannabis, as a non-addictive alternative to opium-derived painkillers – like oxycodone, hydrocodone, and fentanyl – for the treatment of postoperative acute pain. The company also is attempting to develop a transdermal formulation for an over-the-counter “microneedle patch” to be used in managing chronic pain.